| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |